AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
AbbVie (ABBV) CEO Says He Will Not Retire Soon, Despite Rumors - Bloomberg
January 25, 2019 9:39 AM ESTAbbVie (NYSE: ABBV) CEO Says He Will Not Retire Soon, Despite Rumors - Bloomberg
AbbVie (ABBV) Misses Q4 EPS by 3c, Offers FY19 Guidance
January 25, 2019 7:43 AM ESTAbbVie (NYSE: ABBV) reported Q4 EPS of $1.90, $0.03 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $8.31 billion versus the consensus estimate of $8.36 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.65-$8.75, versus the consensus of... More
